Carole Guillonneau

This inventor holds 11 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: The University of Nantes, National Institute of Health and Medical Research, Centre Hospitalier Universitaire De Nantes. Active years: 2018-2025.

USPTO Granted Patents = 11 (Patent Applications = 9)

% Patents Active = 90.9

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 20)

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Nantes, FR (2018 - 2024)
La Chevrolière, FR (2024)

Company Filing History:

10 out of 156

The University of Nantes

patents

9 out of 1,853

National Institute of Health and Medical Research

patents

5 out of 23

Centre Hospitalier Universitaire De Nantes

patents

4. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466866 - MUTATED INTERLEUKIN-34 (IL-34) POLYPEPTIDES AND USES THEREOF IN THERAPY (2025-11-11),

2. 12168694 - Anti-human CD45RC antibodies and uses thereof (2024-12-17),

3. 12146159 - Methods for obtaining regulatory t cells and uses thereof (2024-11-19),

4. 12083163 - Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases (2024-09-10),

5. 12054743 - Method for obtaining T cells from pluripotent stem cells, and uses thereof (2024-08-06),

6. 11090362 - Pharmaceutical composition comprising IL-34 and a mTOR inhibitor (2021-08-17),

7. 10724001 - Methods for obtaining regulatory T cells and uses thereof (2020-07-28),

8. 10591465 - Methods and kits for labeling, detection and isolation of Foxp3regulatory T cells, isolated population of Foxp3regulatory T cells thus obtained and uses thereof (2020-03-17),

9. 10155025 - Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34 (2018-12-18),

10. 10137181 - Isolated donor MHC-derived peptide and uses thereof (2018-11-27),

11. 10105425 - Isolated donor MHC-derived peptide and uses thereof (2018-10-23),

Title: Carole Guillonneau - Innovative Inventor from Nantes

Introduction: Carole Guillonneau is a pioneering inventor hailing from the vibrant city of Nantes, France. With a passion for creativity and problem-solving, she has made significant contributions to the field of innovation.

Latest Patents: Carole Guillonneau's latest patents focus on sustainable energy solutions and eco-friendly technologies, showcasing her commitment to environmental conservation and technological advancement.

Career Highlights: Throughout her illustrious career, Carole Guillonneau has been recognized for her groundbreaking inventions in the fields of renewable energy, smart devices, and healthcare technologies. Her innovative spirit and dedication to improving the world through technology have earned her numerous accolades.

Collaborations: Carole Guillonneau has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and industries has led to the development of cutting-edge products that have a positive impact on society.

Conclusion: Carole Guillonneau's innovative mindset, coupled with her passion for creating a better future through technology, continues to inspire inventors and entrepreneurs around the world. Her contributions to the field of innovation are truly remarkable, and her legacy will undoubtedly shape the future of technology for years to come.